Onco-Occitanie
Onco-Occitanie is the official regional cancer coordination network (DSRC) for France's Occitanie region, providing clinical guidelines, training, the DCC shared medical record, the PR3O speech therapy platform, and regional meetings to oncology professionals and 30+ healthcare institutions.
- Company typePrivate
- Founded2018
- HeadquartersToulouse, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Onco-Occitanie does
Onco-Occitanie is a French non-profit association (loi 1901) that operates as the official Dispositif Spécifique Régional du Cancer (DSRC) for the Occitanie region, a statutory designation granted by the Agence Régionale de Santé (ARS) Occitanie in coordination with the Institut National du Cancer (INCa). Founded in 2018 and headquartered in Toulouse with a regional office in Montpellier, the organization coordinates oncology actors across the entire Occitanie administrative territory to harmonize clinical practices, disseminate guidelines, and structure patient care pathways. It serves oncology professionals (oncologists, radiotherapists, hematologists, nurses, pharmacists, pathologists, and others), 3C Cancer Coordination Centers, institutional partners, and indirectly cancer patients and families.
Its service portfolio spans a secure shared medical record system (Dossier Communicant de Cancérologie / DCC, hosted on a Mediware portal), the PR3O regional speech therapy telehealth platform, recurring newsletters (monthly generalist plus quarterly specialized editions), hybrid regional scientific meetings, the monthly 'Jeudis d'Onco-Occitanie' webinar series, a clinical trials portal, a clinical guidelines and side-effect reference repository, regional provider directories, and continuing education programs. Thematic coverage extends across patient populations (pediatric, adolescent and young adult, geriatric, oncogenetics, rare cancers, pregnant women), treatment modalities (radiotherapy, clinical trials, home hospitalization, interventional radiology, remote medical monitoring), and supportive care.
The organization is entirely publicly funded through ARS Occitanie and INCa grants and operates a free-to-end-user model with no advertising or pharmaceutical sponsorship. It is GDPR/RGPD compliant, retains data within the EU, and is governed by a board led by Pr Françoise Huguet (President) and Dr Bruna Alves (Director), with regional offices in Toulouse and Montpellier serving western and eastern Occitanie respectively.
Onco-Occitanie firmographics
Firmographics- Name
- Onco-Occitanie
- Legal name
- Onco-Occitanie
- Website
- https://onco-occitanie.fr
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Onco-Occitanie is the official regional cancer coordination network (DSRC) for France's Occitanie region, providing clinical guidelines, training, the DCC shared medical record, the PR3O speech therapy platform, and regional meetings to oncology professionals and 30+ healthcare institutions.
- Ownership category
- akta.pro rank
Onco-Occitanie industry classification
Industry- Product category
- Regional Cancer Care Coordination
- NAICS
- Professional, Scientific, and Technical Services (541)
- SIC
- Services-Health Services (8000), Services-Membership Organizations (8600)
- akta.pro primary industry
- Oncology Telemedicine Platforms (HLALAGAH)
- akta.pro secondary industries
- Medical Oncology (HLAKAFAB), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)
Keywords
Where Onco-Occitanie is headquartered
LocationHeadquarters
- HQ city
- Toulouse
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Onco-Occitanie business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels4 records
Onco-Occitanie product offering
Product offeringCore offering
Onco-Occitanie is the regional cancer coordination network (DSRC) for the Occitanie region in France. It delivers a portfolio of coordination services including a shared cancer medical file portal (DCC), regional scientific meetings, monthly educational webinars, clinical trial information portals, oncology guidelines and side-effect databases, professional training, and the PR3O speech therapy platform. The organization serves as a regional hub that federates, trains, and coordinates oncology professionals, cancer coordination centers (3C), and patient pathways across both western and eastern Occitanie.
Product overview
Onco-Occitanie is a Regional Specific Cancer Device (Dispositif Spécifique Régional du Cancer) serving the Occitanie region of France. It operates as a coordination network rather than a traditional software product company, offering a portfolio of services including the Dossier Communicant de Cancérologie (DCC) for secure patient data sharing, regional scientific meetings and webinars (Jeudis d'Onco-Occitanie), clinical trial information portals, reference repositories, provider directories, and the PR3O speech therapy platform. The organization functions as a healthcare coordination hub providing training, guidelines, and collaborative tools for oncology professionals across both East and West Occitanie.
Differentiator
Problem solved
Functional benefit
Products and services
- Dossier Communicant de Cancérologie (DCC) Secure shared medical file system for cancer patients that enables coordination among healthcare professionals across the Occitanie region, accessible via a dedicated Mediware portal. Used by oncology professionals to share patient records and coordinate care.
- Plateforme Régionale Orthophonie Oncologie en Occitanie (PR3O) Regional speech therapy platform for oncology patients providing teleconsultation access and training for liberal speech therapists across Occitanie. Targets cancer patients needing speech therapy and the speech therapists who serve them.
- Réunions régionales (Regional Meetings) Specialized regional scientific meetings covering oncology topics such as lymphomas, myeloma, onco-geriatrics, immunotherapy toxicities, and senology, offered in hybrid (in-person and virtual) formats. Targets oncology professionals in the Occitanie region.
- Jeudis d'Onco-Occitanie Monthly educational webinar series covering cancer care topics such as non-drug interventions, palliative care, and patient support, conducted via video conference. Serves oncology professionals seeking continuing education.
- Essais cliniques en Occitanie (Clinical Trials Portal) Portal providing access to information about clinical trials available in the Occitanie region for cancer patients and healthcare professionals. Targets oncology professionals seeking trial enrollment options and patients exploring treatment opportunities.
- Référentiels et recommandations (Standards and Guidelines) Repository of clinical references, best practice guidelines, and documentation for healthcare professionals involved in cancer care across the Occitanie region.
- Annuaires (Directories) Regional directories of cancer care providers and services in Occitanie, helping professionals and patients locate appropriate healthcare resources.
- Fiches effets secondaires (Side Effects Database) Database of side effect information sheets for cancer treatments, supporting healthcare professionals and patients in managing treatment-related effects.
- Formation (Training Programs) Professional training programs and educational resources for healthcare workers in oncology across the Occitanie region. Targets oncology professionals seeking continuing education and skill development.
- Convention annuelle Onco-Occitanie Annual convention bringing together institutional actors, healthcare professionals, and stakeholders to discuss regional cancer care priorities and initiatives. Targets institutional partners, healthcare professionals, and stakeholders.
- Lettres d'information Onco-Occitanie Regular newsletters (monthly generalist, quarterly coordination, oncogeriatrics, and training editions) providing updates on cancer care news and events in Occitanie.
Companies that use Onco-Occitanie
Customer profileSegments4 records
Ideal customer profiles3 records
Onco-Occitanie technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Onco-Occitanie partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- ARS Occitanie (Agence Régionale de Santé)corePrimary public health authority partner providing institutional funding and strategic direction for regional cancer coordination activities. ARS Occitanie is the regional health agency responsible for health system organization in the territory.
- INCa (Institut National du Cancer)coreNational cancer institute providing funding, guidelines, and strategic framework for regional cancer networks. INCa establishes national standards and recommendations that Onco-Occitanie implements regionally.
- IUCT-Oncopole (Toulouse)coreComprehensive cancer center in Toulouse serving as a key clinical and research partner for Onco-Occitanie. Hosts multiple regional meetings and serves as reference center for various cancer types.
- CHU de MontpelliercoreMajor university hospital center in Montpellier providing clinical expertise and hosting regional oncology events and coordination activities.
- ICM Montpellier (Institut du Cancer de Montpellier)coreRegional cancer institute serving as reference center for Eastern Occitanie. Co-hosts regional events and provides specialized oncology services.
- URPS Orthophonistes OccitanieminorRegional union of speech therapists collaborating on the PR3O platform for orthophony services in oncology care.
- SOR-CC (Société Oncologie Rhône-Alpes-Corse)minorRegional oncology society partnering on professional development and training initiatives.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
Onco-Occitanie competitors and assessment
Company assessmentBroad incumbents
- UNICANCER: National federation of the 18 French Comprehensive Cancer Centers (CLCCs) including IUCT-Oncopole and ICM Montpellier — both core partners of Onco-Occitanie. Operates at a national level on research, care quality, and data, providing an umbrella layer above regional DSRCs.
Direct peers
- Onco AURA: Dispositif Spécifique Régional du Cancer for the Auvergne-Rhône-Alpes region, operating under the same INCa/ARS framework as Onco-Occitanie. It coordinates oncology practice, DCC operations, training, and clinical trials for a different French region, making it the closest structural and functional peer.
- Onco Grand Est: DSRC for the Grand Est region coordinating oncology practice and DCC operations under the same INCa mandate. Same non-profit, publicly-funded model and same portfolio of coordination, training, and clinical trial information services.
- Onco PACA-Corse: DSRC for the Provence-Alpes-Côte d'Azur and Corse regions, comparable in mandate, funding model (ARS + INCa), and service portfolio (DCC, regional meetings, clinical trials portal, training) to Onco-Occitanie.
- Onco Hauts-de-France: Regional cancer coordination network for the Hauts-de-France region under the same DSRC framework. Operates the DCC, regional scientific meetings, and professional training programs — directly mirroring Onco-Occitanie's structure and offering.
- Onco Nouvelle-Aquitaine: Regional cancer coordination network (DSRC) for the Nouvelle-Aquitaine region, performing the same role as Onco-Occitanie — harmonizing oncology practice, hosting the DCC, running training and regional meetings — in a different but structurally identical INCa-mandated framework.
Others
- European Society for Medical Oncology (ESMO): Leading European professional oncology society providing clinical guidelines, congresses, and education for oncologists — the same professional audience Onco-Occitanie serves. Operates at a continental rather than regional scale and does not directly compete.
- Ligue contre le cancer: France's leading cancer-focused non-profit, active in patient support, prevention, research funding, and advocacy. Operates in the same oncology space as Onco-Occitanie but with a different mission (patient advocacy vs. professional coordination), making it a thematically related rather than directly comparable organization.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Onco-Occitanie compliance and trust
Trust signalCompliance1 record
Onco-Occitanie financial estimates
Financial estimateRevenue estimate
Valuation estimate
Onco-Occitanie leadership team
Management profileNumber of profiles
Profiles6 records
Onco-Occitanie funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Onco-Occitanie M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Onco-Occitanie
What does Onco-Occitanie do?
Onco-Occitanie is the regional cancer coordination network (DSRC) for the Occitanie region in France. It delivers a portfolio of coordination services including a shared cancer medical file portal (DCC), regional scientific meetings, monthly educational webinars, clinical trial information portals, oncology guidelines and side-effect databases, professional training, and the PR3O speech therapy platform. The organization serves as a regional hub that federates, trains, and coordinates oncology professionals, cancer coordination centers (3C), and patient pathways across both western and eastern Occitanie.
Is Onco-Occitanie a public or private company?
Onco-Occitanie is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Onco-Occitanie founded?
Onco-Occitanie was founded in 2018. It employs 11 to 50 people.
Where is Onco-Occitanie based?
Onco-Occitanie is headquartered in Toulouse, France, in the Europe region.
Who are Onco-Occitanie's main competitors?
UNICANCER is listed as a broad incumbent. Direct peers are Onco AURA, Onco Grand Est, Onco PACA-Corse, Onco Hauts-de-France and Onco Nouvelle-Aquitaine. Others are European Society for Medical Oncology (ESMO) and Ligue contre le cancer.
Does Onco-Occitanie have an API?
No public API is recorded for Onco-Occitanie.
What industry is Onco-Occitanie in?
Onco-Occitanie's product category is Regional Cancer Care Coordination. Its primary akta.pro industry code is HLALAGAH, Oncology Telemedicine Platforms, with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 541 and its SIC code is 8000.